TAAA: Better Outcomes with Renal Fenestration

Courtesy of Dr. Carlos Fava.

 

Better Outcomes with Renal FenestrationThoraco-abdominal aneurysms (TAAA) are a real challenge for surgeons. So far, endovascular repair have rendered good results in these aneurysms, but branch occlusion continues to be their Achilles’ heel”.

 

449 patients were analyzed, 235 (52%) were treated with branched devices (BEVAR) and 214 (48%) with fenestrated devices (FEVAR). Endoprosthesis were Cook Medical.

 

Mean age in both groups was 70, and except for more men and more smokers in the FEVAR group, there were no significant differences between them.

 

856 vessels were revascularized, 445 by BEVAR and 411 by FEVAR. Technical success was 95% with BEVAR and 99% with FEVAR (p=0.01), during the first 24 hours; those receiving BEVAR presented 2% renal occlusion and 2.1% mortality.

 

Follow up was at 20 months; reintervention rate was similar in both groups (4.7% vs. 5.2%) but renal branch occlusion was higher with BEVAR (9.6% vs. 2.3%; p<0.01).

 

At two years, freedom from renal occlusion was higher with FEVAR (90.4% vs. 97.1%; p<0.01) with no difference in global renal function, but renal occlusion rate was higher following BEVAR.

 

Mortality after ruptured aneurysm was six for each group and survival rate at two years was similar (73.4% vs. 80.9%).

 

Conclusion

At med-term follow up, renal evolution with endoprosthesis in toraco-abdominal aneurysms is satisfactory. Fenestrated devices are associated with lower renal occlusion, compared to branched prosthesis.

 

Editorial Comment

These strategies have solved a great problem for surgery, and show good results in different series.

 

Even though the FEVAR prosthesis have shown fairly better performance in different series, they are tailored specifically to each patient’s anatomy, and are therefore more expensive.

 

Eventually, the development of better devices and 3D printers will make this great challenge easier for interventionists.

 

Original Title: Mid-Term Outcomes of Renal Branches Versus Renal Fenestrations for Thoraco-abdominal Aneurysm Repair.

Reference: T. Martín Gonzalez. Eur J Vasc. Endovasc Surg 2016;52:141-148

 

Courtesy of Dr. Carlos Fava. Favaloro Foundation, Buenos Aires, Argentina.

 

We value your opinion. You can leave your comments, thoughts, questions or suggestions here below.

More articles by this author

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

Atherosclerotic Renal Artery Stenosis: To Revascularize or Not

At long term, atherosclerotic renal artery stenosis (RAS) can lead to hypertension, chronic kidney disease, and cardiac failure. Historically, these patients have been referred...

Endovascular Management of Chronic TEPH: Is Coronary Management Extrapolatable in This Scenario?

Chronic thromboembolic pulmonary hypertension (CTEPH) is a condition that causes significant functional limitation. Its surgical treatment, known as pulmonary endarterectomy (PEA), has improved the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...